Psilera: Seed+Develops next-generation neuroplastogens and psychedelic therapies for neurological conditionsOct 4, 2026RoundOSPsileraCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesHealthtechNorth AmericaSeed